Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Amgen Inc.
Press release submission
| Dec 20, 2021
FDA Approves Otezla® (Apremilast) for the Treatment of Adult Patients With Plaque Psoriasis, Regardless of Severity Level
Press release submission
| Sep 5, 2021
New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps
Press release submission
| Mar 15, 2019
AMGEN, INC.: Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke
Carol Ostrow
| Dec 15, 2017
Amgen Foundation commits $500,000 to help southern California wildfire victims
Carol Ostrow
| Dec 10, 2017
Amgen's Repatha wins FDA approval
Carol Ostrow
| Dec 8, 2017
Amgen presents at Evercore conference
Mark Iandolo
| Nov 1, 2017
Cancer information awareness campaign features conversations with Joan Lunden
Kathy Adams
| Oct 22, 2017
Amgen, Boston Children's Hospital team up for study on unusual pain response
Trending
+
Marketing
Patient Daily
| Apr 22, 2024
Medfluence Senior Director of Business Development on healthcare marketing: 'Patient experience matters more than ever in patient acquisition'
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
Researchers Look for Long-Term Hearing Loss Treatments
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
American Lung Association Report: Utah Receives Poor Grades for Ozone and Particle Pollution
+
Pharmaceuticals
Patient Daily
| Apr 23, 2024
Kentucky Father with Terminal Lung Cancer Now Cancer-Free After Innovative Double-Lung Transplant at Northwestern Medicine
1
2
3
»
Last »